Show simple item record

dc.contributor.authorBunalema, Lydia
dc.date.accessioned2014-08-05T11:06:54Z
dc.date.available2014-08-05T11:06:54Z
dc.date.issued2010-10
dc.identifier.citationBunalema, L. (2010). Anti-mycobacterial activity and acute toxicity of Erythrina abyssinica, Cryptolepis sanguinolenta and Solanum incanum. Unpublished master's dissertation. Makerere University, Kampala, Ugandaen_US
dc.identifier.urihttp://hdl.handle.net/10570/3301
dc.descriptionA Dissertation submitted to the School of Graduates Studies in partial fulfillment of the requirements for the award of the Degree of Master of Science in Pharmacology of Makerere Universityen_US
dc.description.abstractTuberculosis (TB) kills approximately two million people annually. Efforts to treat the disease have been made much more difficult due to development of drug resistant TB strains (MDR and XDR TB) and co-infection with HIV AIDS. There is an urgent need therefore, to search for and develop new, inexpensive and effective anti-TB drugs. Extracts from three plants, Solanum incanum, Cryptolepis sanguinolenta and Erythrina abyssinica used in traditional medicine to treat TB symptoms were screened for anti-mycobacterial properties against a Rifampicin resistant, pan sensitive and Mycobacteria avium strains. In addition, the acute toxicity profile and phytochemistry of the active extracts were studied. The chloroform extract of E. abyssinica was the most active on M. avium wild strain and the rifampicin resistant strain (MIC= 0.3 and 0.39 mg/ml respectively). Against the pansensitive strain the methanol total crude extract was most active (MIC= 0.2 mg/ml). C. sanguinolenta total crude methanol extract was also active against the three strains of mycobacteria; however S. incanum did not show activity on any of the strains. Toxicity studies showed that the two plants had an LD50 of more than 500mg/kg body weight and thus considered to be safe. E. abyssinica extracts and C. sanguinolenta total crude extract contained alkaloids, terpenoids, tannins and flavones. Saponins and phenols were not detected in all extracts. C. sanguinolenta and E. abyssinica have potential to be developed into new anti-TB drugs. The results have also validated traditional knowledge from the local people regarding the use of these species to treat TB.en_US
dc.language.isoenen_US
dc.publisherMakerere Universityen_US
dc.subjectErythrina abyssinicaen_US
dc.subjectCryptolepis sanguinolentaen_US
dc.subjectSolanum incanumen_US
dc.subjectAnti-mycobacterial activityen_US
dc.subjectAcute toxicityen_US
dc.titleAnti-mycobacterial activity and acute toxicity of Erythrina abyssinica, Cryptolepis sanguinolenta and Solanum incanumen_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record